D-1361-2014 Class I Terminated

Recalled by Greenstone Llc — Peapack, NJ

FDA drug recall D-1361-2014 was initiated by Greenstone Llc on Mar 6, 2014 and is designated Class I. Reason for recall: Presence of Foreign Tablets/Capsules: report of a foreign capsule with markings (TKN 250) and identified as a Tikosyn (dofetilide) capsule was found in a bottle of Effexor XR (venlafaxine HCl) 150 mg… The recall status is terminated (terminated May 10, 2017). Affected quantity: 16,018 bottles.

Recall details

Product Type
Drugs
Report Date
Jun 18, 2014
Initiation Date
Mar 6, 2014
Termination Date
May 10, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
16,018 bottles

Product description

Venlafaxine HCl Extended-Release Capsules, 150 mg, 90-count Unit of Use bottles, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977, NDC 59762-0182-2, UPC 3 59762-0182-2 9.

Reason for recall

Presence of Foreign Tablets/Capsules: report of a foreign capsule with markings (TKN 250) and identified as a Tikosyn (dofetilide) capsule was found in a bottle of Effexor XR (venlafaxine HCl) 150 mg capsules that was packaged in the same packaging campaign as the recalled lot

Distribution pattern

Nationwide and Puerto Rico

Code information

V130014, Exp 08/15

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1361-2014
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1361-2014. Report a data issue: hello@regdatalab.com.